Selective sampling using confocal Raman spectroscopy provides enhanced specificity for urinary bladder cancer diagnosis

AbstractIn recent years, Raman spectroscopy has shown substantive promise in diagnosing bladder cancer, especially due to its exquisite molecular specificity. The ability to reduce false detection rates in comparison to existing diagnostic tools such as photodynamic diagnosis makes Raman spectroscopy particularly attractive as a complementary diagnostic tool for real-time guidance of transurethral resection of bladder tumor (TURBT). Nevertheless, the state-of-the-art high-volume Raman spectroscopic probes have not reached the expected levels of specificity thereby impeding their clinical translation. To address this issue, we propose the use of a confocal Raman probe for bladder cancer diagnosis that can boost the specificity of the diagnostic algorithm based on its suppression of the out-of-focus non-analyte-specific signals emanating from the neighboring normal tissue. In this article, we engineer and apply such a probe, having depth of field of approximately 280 μm, for Raman spectral acquisition from ex vivo normal and cancerous TURBT samples. Using this clinical dataset, a diagnostic algorithm based on principal component analysis and logistic regression is developed. We demonstrate that this approach results in comparable sensitivity but significantly higher specificity in relation to high-volume Raman spectral data. The application of only two principal components is sufficient for the discrimination of the samples underlining the robustness of the algorithm. Further, no discordance between replicate spectra is observed emphasizing the reproducible nature of the current diagnostic assessment. The high levels of sensitivity and specificity achieved in this proof-of-concept study opens substantive avenues for application of a confocal Raman probe during endoscopic procedures related to diagnosis and treatment of bladder cancer. FigureArtistic depiction of the working principle of the confocal Raman spectroscopic sensor for urinary bladder cancer diagnosis

[1]  T. Breslin,et al.  Diagnosing Breast Cancer by Using Raman Spectroscopy , 2006 .

[2]  Dietmar Schnorr,et al.  Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study. , 2005, The Journal of urology.

[3]  R. Dasari,et al.  Raman Spectroscopy Provides a Powerful Diagnostic Tool for Accurate Determination of Albumin Glycation , 2012, PloS one.

[4]  Richard G. Brereton,et al.  Applied Chemometrics for Scientists , 2007 .

[5]  Landulfo Silveira,et al.  Raman spectroscopy study of atherosclerosis in human carotid artery. , 2005, Journal of biomedical optics.

[6]  Abigail S Haka,et al.  In vivo Raman spectral pathology of human atherosclerosis and vulnerable plaque. , 2006, Journal of biomedical optics.

[7]  Michael S Feld,et al.  Optical fiber probe for biomedical Raman spectroscopy. , 2004, Applied optics.

[8]  I J Bigio,et al.  Spectroscopic diagnosis of bladder cancer with elastic light scattering , 1995, Lasers in surgery and medicine.

[9]  N Stone,et al.  Assessment of fiberoptic near-infrared raman spectroscopy for diagnosis of bladder and prostate cancer. , 2005, Urology.

[10]  Abigail S Haka,et al.  Real-time Raman system for in vivo disease diagnosis. , 2005, Journal of biomedical optics.

[11]  Yingtian Pan,et al.  Fluorescence guided optical coherence tomography for the diagnosis of early bladder cancer in a rat model. , 2005, The Journal of urology.

[12]  M. Grasso Bladder Cancer: A Major Public Health Issue , 2008 .

[13]  N. Stone,et al.  The use of Raman spectroscopy to identify and characterize transitional cell carcinoma in vitro , 2004, BJU international.

[14]  Michael S. Feld,et al.  Rapid and accurate determination of tissue optical properties using least-squares support vector machines , 2011, Biomedical optics express.

[15]  Alberto Redaelli,et al.  The health economics of bladder cancer: a comprehensive review of the published literature. , 2003, PharmacoEconomics.

[16]  Liangdao Cheng,et al.  [Papillary urothelial neoplasms of low malignant potential]. , 2006, Zhonghua bing li xue za zhi = Chinese journal of pathology.

[17]  Herbert Stepp,et al.  Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder. , 2007, Urology.

[18]  Zoya I. Volynskaya,et al.  Raman spectroscopy: a real-time tool for identifying microcalcifications during stereotactic breast core needle biopsies , 2011, Biomedical optics express.

[19]  Bernhard Walter,et al.  Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study. , 2007, Urology.

[20]  Siyuan Yu,et al.  A miniature confocal Raman probe for endoscopic use , 2009, Physics in medicine and biology.

[21]  D. Bostwick,et al.  Papillary urothelial neoplasms of low malignant potential , 1999, Cancer.

[22]  P. Prem Kiran,et al.  Laser-induced breakdown spectroscopy-based investigation and classification of pharmaceutical tablets using multivariate chemometric analysis. , 2011, Talanta.

[23]  R. Dasari,et al.  Effect of photobleaching on calibration model development in biological Raman spectroscopy. , 2011, Journal of biomedical optics.

[24]  Michael S Feld,et al.  Wavelength selection-based nonlinear calibration for transcutaneous blood glucose sensing using Raman spectroscopy. , 2011, Journal of biomedical optics.

[25]  Christiaan F P van Swol,et al.  In vivo bladder cancer diagnosis by high-volume Raman spectroscopy. , 2010, Analytical chemistry.

[26]  M. Fitzmaurice,et al.  Principles and pitfalls of diagnostic test development: implications for spectroscopic tissue diagnosis. , 2000, Journal of biomedical optics.

[27]  Ishan Barman,et al.  Incorporation of support vector machines in the LIBS toolbox for sensitive and robust classification amidst unexpected sample and system variability. , 2012, Analytical chemistry.

[28]  G. Mowatt,et al.  Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: Systematic review and meta-analysis , 2011, International Journal of Technology Assessment in Health Care.

[29]  Unyime Nseyo,et al.  A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. , 2007, The Journal of urology.

[30]  M. Feld,et al.  Raman Spectroscopy and Fluorescence Photon Migration for Breast Cancer Diagnosis and Imaging , 1998, Photochemistry and photobiology.

[31]  T. Jonges,et al.  Predictors of false positives in 5-aminolevulinic acid-induced photodynamic diagnosis of bladder carcinoma: identification of patient groups that may benefit most from highly specific optical diagnostics. , 2009, Urology.

[32]  Zhiwei Huang,et al.  Optical diagnosis of laryngeal cancer using high wavenumber Raman spectroscopy. , 2012, Biosensors & bioelectronics.

[33]  M. Pacheco,et al.  Differentiating normal and basal cell carcinoma human skin tissues in vitro using dispersive Raman spectroscopy: a comparison between principal components analysis and simplified biochemical models. , 2010, Photomedicine and laser surgery.

[34]  Liang Cheng,et al.  Bladder cancer: epidemiology, staging and grading, and diagnosis. , 2005, Urology.

[35]  R. Dasari,et al.  Development and comparative assessment of Raman spectroscopic classification algorithms for lesion discrimination in stereotactic breast biopsies with microcalcifications , 2013, Journal of biophotonics.